MedTrace Logo

Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury

NCT00252954 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2009-08-20

No results posted yet for this study

Summary

Purpose: To evaluate the efficacy and safety of levetiracetam on chronic neuropathic pain after spinal cord injury, and to examine its effect on spasms and evoked pain.

Conditions

  • Injuries, Spinal Cord
  • Pain

Interventions

DRUG

Levetiracetam

Tablets 2000-3000 mg per day

Sponsors & Collaborators

  • UCB Nordic A/S

    collaborator INDUSTRY

  • Danish Pain Research Center

    lead OTHER

Principal Investigators

  • Nanna B Finnerup, MD · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2008-03-31
Completion
2008-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00252954 on ClinicalTrials.gov